Mcgill University Health Centre/research Institute Of The Mcgill University Health Centre
Clinical trials sponsored by Mcgill University Health Centre/research Institute Of The Mcgill University Health Centre, explained in plain language.
-
Trial halted early: testing a scarring drug for rare lung disease
Disease control TerminatedThis study aimed to see if adding the drug nintedanib to standard immune-suppressing medications was safe and tolerable for adults with myositis-related interstitial lung disease (MA-ILD), a condition where muscle inflammation causes progressive lung scarring. The goal was to slo…
Phase: NA • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Could umbilical cord cells save COVID patients from ventilators?
Disease control TerminatedThis study tested whether a single infusion of stem cells from umbilical cords could help hospitalized COVID-19 patients with severe pneumonia. The goal was to see if the treatment could prevent patients from needing a ventilator or dying. The trial was small, ended early, and co…
Phase: PHASE2 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC